Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina V Lebedeva

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Human Gene Therapy|December 26, 2024
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene TherapyMaria Gioulvanidou, Selenay Sarklioglu, Xinlei Chen, et al.
Molecular Cancer Therapeutics|February 19, 2008
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cellsAdly Yacoub, Margaret A Park, Pankaj Gupta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid MalignanciesLeah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
Anti-Cancer Drugs|July 9, 2010
MDA-7/IL-24 as a cancer therapeutic: from bench to bedsidePaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Nature Microbiology|May 15, 2023
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodiesFengwen Zhang, Jesse Jenkins, Renan V H de Carvalho, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancersSalomon Tendler, Roberto De Gregorio, Paul Balderes, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
The Journal of Chemical Physics|April 4, 2020
Octopus, a computational framework for exploring light-driven phenomena and quantum dynamics in extended and finite systemsNicolas Tancogne-Dejean, Micael J T Oliveira, Xavier Andrade, et al.
The Journal of Chemical Physics|July 17, 2020
The CECAM electronic structure library and the modular software development paradigmMicael J T Oliveira, Nick Papior, Yann Pouillon, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Human Gene Therapy|December 26, 2024
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene TherapyMaria Gioulvanidou, Selenay Sarklioglu, Xinlei Chen, et al.
Molecular Cancer Therapeutics|February 19, 2008
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cellsAdly Yacoub, Margaret A Park, Pankaj Gupta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid MalignanciesLeah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
Anti-Cancer Drugs|July 9, 2010
MDA-7/IL-24 as a cancer therapeutic: from bench to bedsidePaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Nature Microbiology|May 15, 2023
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodiesFengwen Zhang, Jesse Jenkins, Renan V H de Carvalho, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancersSalomon Tendler, Roberto De Gregorio, Paul Balderes, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
The Journal of Chemical Physics|April 4, 2020
Octopus, a computational framework for exploring light-driven phenomena and quantum dynamics in extended and finite systemsNicolas Tancogne-Dejean, Micael J T Oliveira, Xavier Andrade, et al.
The Journal of Chemical Physics|July 17, 2020
The CECAM electronic structure library and the modular software development paradigmMicael J T Oliveira, Nick Papior, Yann Pouillon, et al.
Pageof 7